PT Diastika Biotekindo Tbk (ISX:CHEK) Research & Development: Rp Mil (TTM As of . 20)


ISX:CHEK PT Diastika Biotekindo Tbk ISX:CHEK
2 GF Score
Price Rp125.00
! 1 Warning Sign
View Full Analysis

What is PT Diastika Biotekindo Tbk Research & Development?

PT Diastika Biotekindo Tbk ISX:CHEK 2 Research & Development is Rp Mil as of . 20. GuruFocus rates ISX:CHEK with a GF Score™ of 2/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Diastika Biotekindo Tbk's Research & Development for the six months ended in . 20 was Rp0.00 Mil. PT Diastika Biotekindo Tbk does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

PT Diastika Biotekindo Tbk  (ISX:CHEK) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Diastika Biotekindo Tbk Research & Development Related Terms

PT Diastika Biotekindo Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Diastika Biotekindo Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diastika Biotekindo Tbk Research & Development Chart

PT Diastika Biotekindo Tbk Annual Data
Trend
Research & Development

PT Diastika Biotekindo Tbk Semi-Annual Data
Research & Development
ISX:CHEK
2GF Score
PT Diastika Biotekindo Tbk ISX:CHEK
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Diastika Biotekindo Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp Mil mean?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a Research & Development of Rp Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on PT Diastika Biotekindo Tbk and its competitors.
Is PT Diastika Biotekindo Tbk's Research & Development too high?
PT Diastika Biotekindo Tbk's current Research & Development is Rp Mil. Overall, PT Diastika Biotekindo Tbk has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does PT Diastika Biotekindo Tbk's Research & Development compare to ABT and SYK?
PT Diastika Biotekindo Tbk's Research & Development of Rp Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Diastika Biotekindo Tbk and its competitors. PT Diastika Biotekindo Tbk's current Research & Development is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current Research & Development of Rp Mil. The current Research & Development is Rp Mil. PT Diastika Biotekindo Tbk's overall GF Score™ is 2/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current Research & Development is Rp Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diastika Biotekindo Tbk Business Description

Address Jalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.
2GF Score

Get the complete analysis for ISX:CHEK

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp125.00
Price